Huminsulin 30/70 Cartridge (3ml Each) is a premixed insulin formulation containing 70% insulin isophane (NPH insulin) and 30% human insulin, designed for the management of diabetes mellitus requiring insulin therapy. This combination provides both intermediate-acting and short-acting insulin components, facilitating improved glycemic control by addressing both basal and prandial insulin requirements. Insulin isophane acts to maintain basal insulin levels, while human insulin rapidly reduces postprandial blood glucose levels. Huminsulin 30/70 is indicated for patients with type 1 diabetes mellitus and insulin-dependent type 2 diabetes mellitus who require insulin to achieve optimal glycemic control. The cartridge is intended for use with compatible insulin delivery devices, ensuring accurate dosing and ease of administration. Dosage and administration should be individualized based on patient needs, blood glucose monitoring, and clinical response. Caution is advised to avoid hypoglycemia, and patients should be educated on recognizing and managing low blood sugar episodes. This insulin preparation should be stored under recommended conditions to preserve potency. Huminsulin 30/70 offers a reliable and effective option for insulin therapy, supporting comprehensive diabetes management in clinical practice.